Skip to main content
. 2025 Feb 12;59(3):438–449. doi: 10.1007/s43441-025-00753-7

Table 2.

UK-Windsor Framework vs. EU Regulations.

Comparative analysis UK Windsor framework EU pharmaceutical regulations (EMA)
Regulatory Authority

MHRA governs the regulation of medicinal products in UK including Northern Ireland (NI)

It operates independently of EMA but maintains cooperation wherever applicable

European Medicines Agency (EMA) oversees regulations of medicinal product across its member states
Marketing Authorisation

All product licenses will be primarily considered to be UK wide

All UK application must go through MHRA-specific approval process post Windsor Framework

No automatic cross recognition with EMA, separate approval process required for products already authorised in EU

Multiple pathways: Centralised, Decentralised, Mutual recognition and National procedure remains unchanged for market approval across all member states of EU
Pharmacovigilance

Independent Pharmacovigilance system is followed by MHRA

Yellow card scheme for reporting adverse event reporting (ADRs)

EudraVigilance database for monitoring and reporting adverse event reporting (ADRs) across EU member states
Pricing and Reimbursement

MHRA determines cost and reimbursement of medicines

Separate pricing policies are available for entire UK

Each EU member state determines pricing and reimbursement though EMA encourages transparency and cross border referencing of prices
Labelling Windsor establishes new labeling (‘UK Only’) requirements in accordance with MHRA Labelling requirements are established as per EMA directive
Regulatory Compliance MHRA maintains a uniform compliance in Good Manufacturing Practice (GMP) inspections and safety reporting EMA coordinates with all member states to ensure organized approach of regulation
Market Access and Trade

Access to any authorised product is uniform throughout UK (including NI)

Trade barriers cease to exist within the UK as facilitated in Windsor Framework

Market access in EU single market is independent of authorisation by MHRA

Trade barriers will come into existence only between EU and NI